Where do Bristol-Myers Squibb's ratios come from?

Every ratio is computed from Bristol-Myers Squibb's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	70.5%0.0pp	71.1%0.0pp	69.5%-5.4pp	70.3%-5.1pp	70.5%-5.2pp
Net margin	15%+3.8pp	14.6%+33.3pp	12.4%+27.7pp	10.4%+24.5pp	11.2%+24.7pp
EBITDA margin	27.2%-2.2pp	27.7%+25.5pp	26.6%+19.6pp	27.1%+19.3pp	29.4%+20.6pp
Free cash flow margin	24.6%-2.9pp	26.7%-2.2pp	31.9%+2.8pp	30.6%+2.7pp	27.5%0.0pp
Returns
Return on equity	38.8%+7.3pp	40.5%+79.9pp	33.4%+64.9pp	28.9%+55.6pp	31.6%+57.0pp
Return on assets	8.1%+2.5pp	7.7%+17.3pp	6.3%+14.1pp	5.3%+12.2pp	5.6%+11.9pp
Return on invested capital	13%+4.2pp	12.5%+27.2pp	10.6%+22.0pp	8.3%+18.5pp	8.8%+18.1pp
Efficiency
Asset turnover	0.5×0.0×	0.5×0.0×	0.5×0.0×	0.5×0.0×	0.5×0.0×
Inventory turnover	5.3×+0.3×	5.3×0.0×	4.8×-0.9×	4.9×-1.2×	5×-1.3×
Liquidity
Current ratio	1.4×+0.1×	1.3×0.0×	1.3×0.0×	1.2×+0.1×	1.3×+0.2×
Quick ratio	1.3×+0.1×	1.1×0.0×	1.2×+0.1×	1.1×+0.1×	1.2×+0.2×
Cash ratio	0.5×0.0×	0.4×0.0×	0.6×+0.2×	0.5×+0.2×	0.5×+0.1×
Leverage
Debt-to-equity	2.2×-0.6×	2.6×-0.6×	2.7×-0.3×	2.8×-0.3×	2.9×-0.5×
Debt-to-assets	0.5×0.0×	0.5×0.0×	0.5×0.0×	0.5×0.0×	0.5×0.0×
Net debt / EBITDA	2.7×-0.1×	2.8×-36.3×	2.6×-10.1×	2.8×-10.0×	2.8×-8.8×
Valuation
Market capitalization	$123.83B-0.2%	$109.81B-4.3%	$91.8B-12.5%	$95.71B+13.7%	$124.1B+13.2%
Enterprise value	$158.92B-2.6%	$146.74B-5.7%	$125.26B-14.7%	$132.49B+1.6%	$163.11B+4.4%
Price / earnings	17×-6.2×	15.6×—	15.4×—	19.2×—	23.2×—
Price / sales	2.6×-0.1×	2.3×-0.1×	1.9×-0.3×	2×+0.2×	2.6×+0.2×
Price / book	6.2×-1.0×	5.9×-1.1×	4.9×-1.2×	5.5×+0.5×	7.1×+0.5×
EV / EBITDA	12×+0.4×	11×-138×	9.8×-34.7×	10.3×-25.9×	11.6×-27.2×
EV / sales	3.3×-0.1×	3×-0.2×	2.6×-0.5×	2.8×0.0×	3.4×0.0×
Free cash flow yield	9.6%-0.9pp	11.7%-0.5pp	16.7%+3.5pp	15.2%-0.1pp	10.5%-0.9pp
Earnings yield	5.9%+1.6pp	6.4%+14.3pp	6.5%+13.4pp	5.2%+13.0pp	4.3%+9.9pp
Dividend yield	4.1%+0.1pp	4.6%+0.4pp	5.4%+0.9pp	5.2%-0.5pp	4%-0.4pp
PEG ratio	0.5×—	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Bristol-Myers Squibb.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Bristol-Myers Squibb's ratios come from?: Every ratio is computed from Bristol-Myers Squibb's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.